We compared the anti-tumor response of Mertk-/-V1, Mertk-/-V2, and Mertk-/-V3 mice in a model of ICI-refractory melanoma (YUMM1.7), as well as in an orthotopic brain tumor mouse model (GL261). Here, MERTK is linked to neoplasm.